drugset / Trial / NCT00412997
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The phase I study will evaluate the safety, efficacy and pharmacokinetics of LBH589B in adult patients with advanced solid tumors or Cutaneous T-cell lymphoma
Timeline
- Start
- 2006-11
- Primary completion
- 2008-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | — | Oral |